127 related articles for article (PubMed ID: 8998396)
1. Impaired exploratory behaviour after DSP-4 treatment in rats: implications for the increased anxiety after noradrenergic denervation.
Harro J; Oreland L; Vasar E; Bradwejn J
Eur Neuropsychopharmacol; 1995 Dec; 5(4):447-55. PubMed ID: 8998396
[TBL] [Abstract][Full Text] [Related]
2. Chronic mild unpredictable stress after noradrenergic denervation: attenuation of behavioural and biochemical effects of DSP-4 treatment.
Harro J; Häidkind R; Harro M; Modiri AR; Gillberg PG; Pähkla R; Matto V; Oreland L
Eur Neuropsychopharmacol; 1999 Dec; 10(1):5-16. PubMed ID: 10647090
[TBL] [Abstract][Full Text] [Related]
3. Housing influences exploration and social interaction of control and DSP-4-treated rats.
Cornwell-Jones CA; Palfai T; Krasenbaum D; Byer E; Clark R; Kinnard K
Physiol Behav; 1992 Aug; 52(2):271-6. PubMed ID: 1381838
[TBL] [Abstract][Full Text] [Related]
4. Novelty-oriented behavior in the rat after selective damage of locus coeruleus projections by DSP-4, a new noradrenergic neurotoxin.
Delini-Stula A; Mogilnicka E; Hunn C; Dooley DJ
Pharmacol Biochem Behav; 1984 Apr; 20(4):613-8. PubMed ID: 6728877
[TBL] [Abstract][Full Text] [Related]
5. Lesioning of locus coeruleus projections by DSP-4 neurotoxin treatment: effect on amphetamine-induced hyperlocomotion and dopamine D2 receptor binding in rats.
Harro J; Meriküla A; Lepiku M; Modiri AR; Rinken A; Oreland L
Pharmacol Toxicol; 2000 May; 86(5):197-202. PubMed ID: 10862500
[TBL] [Abstract][Full Text] [Related]
6. Effects of low dose N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine administration on exploratory and amphetamine-induced behavior and dopamine D2 receptor function in rats with high or low exploratory activity.
Alttoa A; Kõiv K; Eller M; Uustare A; Rinken A; Harro J
Neuroscience; 2005; 132(4):979-90. PubMed ID: 15857703
[TBL] [Abstract][Full Text] [Related]
7. The effects of CRA 1000, a non-peptide antagonist of corticotropin-releasing factor receptor type 1, on adaptive behaviour in the rat.
Harro J; Tõnissaar M; Eller M
Neuropeptides; 2001 Apr; 35(2):100-9. PubMed ID: 11384205
[TBL] [Abstract][Full Text] [Related]
8. Changes in cholecystokinin receptor binding in rat brain after selective damage of locus coeruleus projections by DSP-4 treatment.
Harro J; Jossan SS; Oreland L
Naunyn Schmiedebergs Arch Pharmacol; 1992 Oct; 346(4):425-31. PubMed ID: 1436127
[TBL] [Abstract][Full Text] [Related]
9. Increase in beta- and alpha 1-adrenoceptor binding sites in the rat brain and in the alpha 1-adrenoceptor functional sensitivity after the DSP-4-induced noradrenergic denervation.
Mogilnicka E
Pharmacol Biochem Behav; 1986 Oct; 25(4):743-6. PubMed ID: 3024179
[TBL] [Abstract][Full Text] [Related]
10. Cholecystokinin peptides and receptor binding in rat brain after DSP-4 treatment.
Löfberg C; Harro J; Matto V; Oreland L
Neuropeptides; 1998 Apr; 32(2):103-8. PubMed ID: 9639247
[TBL] [Abstract][Full Text] [Related]
11. Functional supersensitivity to adrenergic agonists in the rat after DSP-4, a selective noradrenergic neurotoxin.
Dooley DJ; Mogilnicka E; Delini-Stula A; Waechter F; Truog A; Wood J
Psychopharmacology (Berl); 1983; 81(1):1-5. PubMed ID: 6415724
[TBL] [Abstract][Full Text] [Related]
12. CR 2945: a novel CCKB receptor antagonist with anxiolytic-like activity.
Revel L; Mennuni L; Garofalo P; Makovec F
Behav Pharmacol; 1998 May; 9(3):183-94. PubMed ID: 9832933
[TBL] [Abstract][Full Text] [Related]
13. CCK receptor antagonists in animal models of anxiety: comparison between exploration tests, conflict procedures and a model based on defensive behaviours.
Griebel G; Perrault G; Sanger DJ
Behav Pharmacol; 1997 Nov; 8(6-7):549-60. PubMed ID: 9832969
[TBL] [Abstract][Full Text] [Related]
14. DSP-4-induced depletion of brain norepinephrine produces opposite effects on exploratory behavior 3 and 14 days after treatment.
Berridge CW; Dunn AJ
Psychopharmacology (Berl); 1990; 100(4):504-8. PubMed ID: 2320711
[TBL] [Abstract][Full Text] [Related]
15. Central noradrenergic lesion induced by DSP-4 impairs the acquisition of avoidance reactions and prevents molecular changes in the amygdala.
Radwanska K; Nikolaev E; Kaczmarek L
Neurobiol Learn Mem; 2010 Oct; 94(3):303-11. PubMed ID: 20650329
[TBL] [Abstract][Full Text] [Related]
16. Effects of central noradrenaline depletion by the selective neurotoxin DSP-4 on the behaviour of the isolated rat in the elevated plus maze and water maze.
Lapiz MD; Mateo Y; Durkin S; Parker T; Marsden CA
Psychopharmacology (Berl); 2001 May; 155(3):251-9. PubMed ID: 11432687
[TBL] [Abstract][Full Text] [Related]
17. DSP-4 lesion of locus coeruleus does not affect spontaneous predatory behaviour in cats.
Kubiak P; Zagrodzka J
Acta Neurobiol Exp (Wars); 1993; 53(4):525-34. PubMed ID: 7509107
[TBL] [Abstract][Full Text] [Related]
18. Effects of noradrenaline depletion in the brain on response on novelty in isolation-reared rats.
Lapiz MD; Mateo Y; Parker T; Marsden C
Psychopharmacology (Berl); 2000 Oct; 152(3):312-20. PubMed ID: 11105942
[TBL] [Abstract][Full Text] [Related]
19. Restraint-stress-induced changes in exploratory behavior appear to be mediated by norepinephrine-stimulated release of CRF.
Berridge CW; Dunn AJ
J Neurosci; 1989 Oct; 9(10):3513-21. PubMed ID: 2795137
[TBL] [Abstract][Full Text] [Related]
20. The effects of cholecystokinin A and B receptor antagonists on exploratory behaviour in the elevated zero-maze in rat.
Matto V; Harro J; Allikmets L
Neuropharmacology; 1997 Mar; 36(3):389-96. PubMed ID: 9175618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
